HIV-1 vaccine (Sumagen)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHIV-1 vaccine (Sumagen)
Drug Alias NameKilled-whole HIV-1 vaccineSAV-001SAV-001H
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWestern UniversityOmnia Biologics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumagen
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A